You are here

Clinical Trials: Cord Blood

Comment

Discuss
Conditions:   Acute Myeloid Leukemia;   Myelodysplastic Syndrome
Interventions:   Biological: haplo-identical cells (donor);   Biological: umbilical cord blood unit (CBU)
Sponsor:   Weill Medical College of Cornell University
Recruiting
Condition:   Viral Infections After HSCT
Intervention:   Biological: VSTs
Sponsor:   Catherine Bollard
Recruiting - verified August 2017
Condition:   Severe Hypoxic-ischemic Encephalopathy
Interventions:   Drug: HPDSC;   Drug: Cord blood
Sponsors:   New York Medical College;   Celgene
Not yet recruiting - verified May 2017
Conditions:   Leukemia;   Lymphoma
Interventions:   Drug: Rituximab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Radiation;   Procedure: Fucosylated Regulatory T Cells;   Procedure: Cord Blood Infusions;   Drug: Mycophenolate mofetil;   Drug: Sirolimus;   Procedure: Bone Marrow Aspiration;   Drug: G-CSF;   Procedure: Non-Fucosylated Regulatory T Cells
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI);   Targazyme, Inc.;   Cancer Prevention Research Institute of Texas
Recruiting - verified April 2017
Condition:   Stroke
Intervention:   Biological: allogeneic umbilical cord blood
Sponsor:   Joanne Kurtzberg, MD
Completed - verified March 2017
Condition:   Bronchopulmonary Dysplasia
Intervention:   Biological: Human Umbilical Cord Blood Derived-Mesenchymal Stem Cells
Sponsors:   Medipost America Inc.;   Medipost Co Ltd.
Completed
Conditions:   Sickle Cell Disease;   Thalassemia
Intervention:   Biological: CordIn
Sponsor:   Gamida Cell ltd
Recruiting - verified September 2016
Condition:   Metabolic Disorders
Intervention:   Biological: ProHema-CB Transplant
Sponsor:   Fate Therapeutics
Terminated - verified October 2015
Condition:   Leukemia, Myeloid
Interventions:   Drug: IV Thiotepa;   Drug: IV Fludarabine;   Drug: IV Busulfan;   Drug: IV Anti-thymocyte globuline
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting
Condition:   Acute Myeloid Leukemia
Interventions:   Drug: chemotherapy (Mitoxantrone, Cytarabine);   Drug: Placebo;   Drug: Crenolanib;   Other: Allogeneic stem cell transplantation
Sponsor:   University of Ulm
Recruiting - verified March 2017

Pages